Integrated individualised treatment of colorectal cancer
Introduction: Advanced colorectal cancer (CRC) has a poor prognosis with a 5-year survival of only 5% despite treatment with chemotherapeutic agents. The ATP- Tumour Chemosensitivity Assay (ATP-TCA) has been used to demonstrate heterogeneity of chemosensitivity between tumours of the same tissue typ...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2005
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.425669 |